Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway

This publication has 48 references indexed in Scilit:

• Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
  New England Journal of Medicine, 1999
• Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
  Published by Elsevier ,1999
• Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis
  Journal of Biological Chemistry, 1998
• FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
  Cell, 1996
• Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death
  Cell, 1996
• Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
  Molecular Immunology, 1993
• Apoptosis
  Immunology Today, 1993
• Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel disease
  Digestive Diseases and Sciences, 1992
• The Pathophysiology of Tumor Necrosis Factors
  Annual Review of Immunology, 1992
• Lymphocytes play the music but the macrophage calls the tune
  Immunology Today, 1991